MS&AD Ventures and Mouro Capital helped privacy management technology provider Skyflow secure $45m while neurotherapeutics developer Cecerin revealed $40m from investors including Nestlé.

AstraZeneca, Eli Lilly and Sinopharm all achieved exits as the cancer therapy developer listed on the Hong Kong Stock Exchange at a reported valuation of nearly $1.1bn.

The cancer immunotherapy developer, which counts Novo and Lundbeck as investors, filed to raise up to $100m in its initial public offering.

Service robot manufacturer Uditech completed a $31.1m Guanda and 58.com-backed round while Mayo Clinic co-led privacy technology developer TripleBlind's $24m series A round.

Intelerad has bought the Mayo Clinic-backed medical image software developer to further expand its platform for reading, storing and sharing diagnostic imaging.

SumUp is purchasing the Rogers Communications-backed payment and marketing software provider to bolster its trans-Atlantic presence.

Corporate-backed communications monetisation technology developer Matrixx Software raised $50m from Francisco Partners while cancer drug developer Abalos took the same in a BIVF-backed round.

The Real Web-backed automotive marketing software developer intends to use the IPO proceeds to accelerate the development of new products, fuel its M&A strategy and expand its customer base.

The Lockheed Martin-backed PCB manufacturing software provider’s reverse takeover deal will involve it listing on the Nasdaq Stock Market.

The Barracuda Networks-backed expense management software provider has filed to go public having disclosed less than $28m in funding.